The world’s second largest pharmaceutical company, GlaxoSmithKline, is investing close to €100 million in a new manufacturing facility in Dresden, Germany, for flu vaccines.
link from in-pharmatech
Tuesday, August 09, 2005
GSK to double flu vaccine production capacity
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment